Search
Displaying results 4391 - 4400 of 9670 in total
ALGRX 1207
go.drugbank.com/drugs/DB06482ExperimentalALGRX 1207 entered clinical trials for cutaneous neuropathic pain, such as chemotherapy-induced neuropathy, in 2006. It was being developed by Anesiva, but trials have halted.
Recombinant alpha 1-antitrypsin
go.drugbank.com/drugs/DB05481Investigationalkallikrein, as well as neutrophil elastase. … The company has indicated that other formulations for gastroenterological and urological indications will also be developed.
XL999
go.drugbank.com/drugs/DB05014InvestigationalXL999 has the potential to provide benefit to patients with lung cancer and acute myelogenous leukemia. … XL999 has the potential to prevent tumor growth — both directly by a novel effect on tumor cell proliferation and indirectly through inhibition of the host angiogenic response.